- Open Access
Erratum to: Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
BMC Psychiatryvolume 15, Article number: 202 (2015)
The original article was published in BMC Psychiatry 2013 13:237
In Figure three (Fig. 1 here), the uppermost solid line represents placebo and the lower solid line (at 0.5 h), represents Ritalin LA® 20 mg capsule. In addition, labelling of the x-axis should read “0.5, 1, 2, 3, 4, 6, 8” hours.
Coghill D, Banaschewski T, Zuddas A, Pelaz A, Gagliano A, Doepfner M. Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies. BMC Psychiatry. 2013;13:237.
Lopez F, Silva R, Pestreich L, Muniz R. Comparative efficacy of two once daily methylphenidate formulations (Ritalin LA and Concerta) and placebo in children with attention deficit hyperactivity disorder across the school day. Paediatr Drugs. 2003;5:545–55.
David Coghill and Tobias Banaschewski are joint first authors.
Antonella Gagliano and Manfred Doepfner are joint last authors.
The online version of the original article can be found under doi:10.1186/1471-244X-13-237.